Daniel R. Chevallard - 21 Mar 2024 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Signature
/s/ Evert Schimmelpennink, as Attorney-in-Fact
Issuer symbol
LENZ
Transactions as of
21 Mar 2024
Net transactions value
$0
Form type
4
Filing time
25 Mar 2024, 20:36:10 UTC
Previous filing
13 Mar 2024
Next filing
15 May 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LENZ Stock Option (right to buy) Award $0 +200,000 $0.000000 200,000 21 Mar 2024 Common Stock 200,000 $15.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 21, 2024.